Ab0527 Pharmacogenetics and Pharmacodynamics of Response to Apremilast in a Phase 3 Clinical Study in Subjects With Active Behçet's Disease
Year: 2020
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Authors: J. Maranville, I. Medvedeva, R. Yang, M. Chen, L.R. Fang, S. Collazo, S. Mccue, P. Schafer
Institution: Celgene (United States)
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: apremilast, Behçet's disease, pharmacogenetics, pharmacodynamics, phosphodiesterase-4 inhibitors, oral ulcers, HLA-B*57:01, IL-10, IL-17A, IL-23, interleukin-8, interferon-gamma, TNF-α, interferon lambda, Th17 cells, regulatory T cells, CD3+ T cells, plasma biomarkers, treatment response biomarkers, genetic polymorphism
Open Access status: closed
OpenAlex ID: W3094539773
